Advasa Holdings, Inc. 為一家金融科技及服務公司,在日本提供一系列金融服務及解決方案。公司總部位於日本港區。
財務指標
營業收入
2026-06-30
$6.89M
2026-03-31
$5.88M
2025-12-31
-$249K
2025-09-30
$6.13M
營業支出
2026-06-30
$1.62M
2026-03-31
$8.8M
2025-12-31
$2.82M
2025-09-30
$4.27M
淨利潤
2026-06-30
$3.53M
2026-03-31
-$1.69M
2025-12-31
-$2.08M
2025-09-30
$1.22M
淨利潤率
2026-06-30
51.16%
2026-03-31
-28.82%
2025-12-31
836.54%
2025-09-30
20%
每股收益
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
息稅折舊攤銷前利潤
2026-06-30
$5.27M
2026-03-31
-$2.91M
2025-12-31
-$3.07M
2025-09-30
$1.87M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$6.89M
$5.88M
-$249K
$6.13M
營業支出
$1.62M
$8.8M
$2.82M
$4.27M
淨利潤
$3.53M
-$1.69M
-$2.08M
$1.22M
淨利潤率
51.16%
-28.82%
836.54%
20%
每股收益
--
--
--
--
息稅折舊攤銷前利潤
$5.27M
-$2.91M
-$3.07M
$1.87M
有效稅率
--
--
--
--
常見問題
ADBT operates in the healthcare technology sector, focusing on digital health platforms and data-driven solutions for healthcare providers. The company develops software and services that help streamline clinical workflows, improve patient engagement, and support better decision-making through analytics. Its offerings are designed to address the growing demand for efficient, connected healthcare systems in the United States and beyond. For the most current description of ADBT's business segments and services, refer to the company profile on this page.
Recent performance for ADBT is best assessed using the latest price data and chart displayed on this page. Stock movements can be influenced by quarterly results, industry trends, and broader market conditions. Rather than relying on outdated figures, review the current quote, percentage change, and trading volume shown here to understand how ADBT has been trading over recent sessions. This provides a real-time view of momentum and price action.
Common valuation metrics for ADBT include the price-to-earnings ratio, price-to-sales ratio, and enterprise value-to-EBITDA. These help gauge whether the stock is trading at a premium or discount relative to peers and its own history. Because ADBT operates in a growth-oriented sector, investors may also consider revenue growth rates and margins alongside traditional multiples. The latest metrics are available on this page, and they should be compared with industry benchmarks for context.
ADBT can be traded in pre-market and after-hours sessions through many brokers, though liquidity is typically lower than during regular trading hours. Extended-hours trading allows investors to react to news released outside standard market times, but it often comes with wider spreads and higher volatility. Not all brokers offer this service, and order types may be limited. Check with your brokerage for specific availability and any associated fees or restrictions.
Whether ADBT pays dividends depends on its current capital allocation policy. Some companies in the healthcare technology space prioritize reinvestment in growth over returning cash to shareholders. To confirm if ADBT distributes dividends and to see the latest payout details, review the dividend section on this page. Any changes to the dividend policy would be announced through official company filings or press releases.
Key risks for ADBT include competitive pressures in healthcare technology, regulatory changes affecting digital health, and dependence on securing and retaining enterprise clients. The company may also face risks related to data privacy, cybersecurity, and the pace of adoption of new technologies. Additionally, broader market volatility and interest rate movements can impact growth-oriented stocks. Investors should review ADBT's risk factors in its annual report for a comprehensive list.